| COVID-19 | Coronavirus Disease 2019 |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| IgG | Immunoglobulin G |
| N-glycan | N-linked glycan |
| G0 | Agalactosylated IgG glycan |
| G1 | Monogalactosylated IgG glycan |
| G2 | Digalactosylated IgG glycan |
| F | Core-fucosylated IgG glycan |
| B | IgG glycan with bisecting N-acetylglucosamine (GlcNAc) |
| S | Sialylated IgG glycan |
| Fc | Fragment crystallizable region of IgG |
| ADCC | Antibody-dependent cellular cytotoxicity |
| CDC | Complement-dependent cytotoxicity |
| HILIC | Hydrophilic Interaction Liquid Chromatography |
| UHPLC | Ultra-High-Performance Liquid Chromatography |
| EDTA | Ethylenediaminetetraacetic acid |
| PNGase F | Peptide-N-Glycosidase F |
| CRP | C-reactive protein |
| ALP | Alkaline phosphatase |
| ICU | Intensive Care Unit |
| FDR | False Discovery Rate |